A CCH Case Study: Addressing the Real Cause of Conjunctivochalasis (CCH)


An optometrist in my office referred a 69-year-old male patient, who for years had been treated for dryeye with RESTASIS, and occasionally Lotemax. At the time, he also wore scleral lenses to try to combat his dry eye. After years of struggling and trying different treatments, he still had no relief.

First Study to Demonstrate Corneal Nerve Regeneration in Patients with Dry Eye Disease with the Use of PROKERA

At the recent American Academy of Ophthalmology Meeting in New Orleans, I presented on results of “Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease” recently published in The Journal of Ophthalmology, 2017 (John, et al.). This study is the first study to show that cryopreserved amniotic membrane is correlated with corneal nerve regeneration in patients with dry eye disease (DED).

Ocular Surface Regeneration in Dry Eye Disease: New Article and Case Study

For patients with chronic dry eye disease causing corneal conditions such as SPK or filamentary keratitis, PROKERA® offers a viable option for immediate intervention as a powerful anti-inflammatory with the long-lasting benefit of regenerative healing.

An Account Representative’s Perspective: Five Key Things I Learned from Being Treated with PROKERA

As an account representative for Bio-Tissue, I look forward to visiting with doctors and staff and talking about the benefits of PROKERA. However, when I recently became a patient, I learned even more about the benefits of this biologic corneal bandage with cryopreserved amniotic membrane. This experience not only helped heal my ocular surface, but also provided valuable information I can pass on to doctors and staff.

Ways to Educate our Dry Eye Patients and Make Them More at Ease

Our practice has always had a strong focus on cataract surgery, and from its inception has been at the forefront of treating patients with dry eye disease (DED). Early on, we realized the importance of having a healthy ocular surface for our patients prior to surgery. As such, all of us within the practice pay particular attention when treating patients with DED. We are very fortunate to have the most up-to-date equipment and tools available to help these patients.

Part 1: The Paradigm Shift in Treating Dry Eye

In part one of a two–part series, Josh Johnston, OD discusses the paradigm shift in treating patients with dry eye.

Treating dry eye disease (DED) has truly evolved over the past years, and even more so recently with new diagnostics, therapies and FDA-approved drugs. We all know DED is progressive and can be hard to treat, which is actually one of the reasons I like it so much. It’s an exciting time for those of us treating DED. The paradigm shift has changed and there are new, novel products and therapies at our disposal that allow us to provide better options to patients and improve clinical outcomes.

Bio-Tissue’s Dry Eye Center of Excellence Program

Our company’s groundbreaking scientific research in the study of regenerative medicine has led to the development of innovative products that are used worldwide by eye care professionals to treat ocular surface disease (OSD), including dry eye. In order to help you leverage our products, elevate the level of care you provide to your patients, improve clinical outcomes, and grow your practice, we developed the Dry Eye Center of Excellence Program (DECE).

Part 2: The Business Impact of Offering Cliradex in Your Practice

In part two of her series, Patti Barkey, CEO, Bowden Eye & Associates, in Jacksonville, Fla., discusses how Cliradex has assisted in practice efficiency, clinical outcomes and how it has improved business and their bottom line.

Part 1: The Business Impact of Offering Cliradex in Your Practice

In part one of a two-part series, Patti Barkey, CEO, Bowden Eye & Associates, in Jacksonville, Fla., discusses why they decided to implement Cliradex in their practice, how it fits into their “Dry Eye Disease" toolbox, and how it is used.

The Psychology of a Dry Eye Patient

In my experience taking care of patients with dry eye, there is a certain population whose success or failure with treatment, to a certain degree, hinges on how they feel about it emotionally.

As doctors, we see a problem and treat it, but then we move on with our day and our next patient. We may not always understand the albatross these patients face each day – whether it be working at their computer, driving, or performing other daily activities while their vision is blurry or their eyes are burning or tearing. From a survey perspective we appreciate the quality of life issue; but from a day-to-day misery that these patients experience, it’s hard to truly wrap our minds around this as doctors. As with anything in life, some patients handle things better than others, and unfortunately for some dry eye patients the potential for failure of treatment can be perpetuated by the emotional burden they carry.